Creatine and Glutamine in Steroid-Naive Duchenne Muscular Dystrophy
Status:
Completed
Trial end date:
2006-12-01
Target enrollment:
Participant gender:
Summary
This study will help to determine the effectiveness of glutamine and creatine as a possible
therapy for DMD. Boys with DMD who are enrolled in this trial will be randomly chosen to
receive creatine monohydrate or glutamine or an inactive placebo orally for six months. Once
a month during the six-month treatment period, the study participants will have their muscle
strength evaluated using manual and computerized testing methods. This study will be
conducted at several CINRG Centers throughout the U.S., Belgium, Israel and Puerto Rico. This
study is supported by the Muscular Dystrophy Association.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Cooperative International Neuromuscular Research Group